Revenue from Contracts with Customers (Tables)

3 Months Ended

Mar. 31, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table summarizes revenue by revenue source as follows:

	Three Months Ended March 31,
Major Products/Service Lines (in thousands)	2024		2023
Product revenue, net(1)	$	369,313	$	292,256
License and royalty revenues	662		8,528
Total revenues	$	369,975	$	300,784

________________________________

(1)The Company’s product revenue includes PYLARIFY and DEFINITY among other products. This category represents the delivery of physical goods. The Company applies the same revenue recognition policies and judgments for all its principal products.

Revenue by product category on a net basis is as follows:

	Three Months Ended March 31,
(in thousands)	2024		2023
PYLARIFY	$	258,870	$	195,470
Other radiopharmaceutical oncology	384		717
Total radiopharmaceutical oncology	259,254		196,187
DEFINITY	76,564		68,824
TechneLite	21,714		20,986
Other precision diagnostics	5,932		5,807
Total precision diagnostics	104,210		95,617
Strategic partnerships and other revenue	6,511		8,980
Total revenues	$	369,975	$	300,784